Efficacy and Safety of a Repurposed Drug Added to the Combination of Len Plus Pem in Advanced Endometrial Cancer
Clinical trial NCT05077215 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05077215
- Sponsor
- Evergreen Therapeutics, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-12-01
- Primary completion
- 2027-12-01
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.